Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment

NCT04343287 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndrome

Interventions

DRUG: BRM421
DRUG: Placebo

Sponsor

BRIM Biotechnology Inc.